Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarten J Postma

Showing results (91-100 of 485) with videos related to

Pageof 49
Sort By:
Pharmacoeconomics - Open|March 2, 2026
Cost Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in Older Adults in PortugalEleftherios Zarkadoulas, Fábio Silva, Joana Alves, et al.
Expert Review of Vaccines|July 31, 2008
Cost-effectiveness of varicella vaccination programs: an update of the literatureMark H Rozenbaum, Albert Jan van Hoek, Stefan Vegter, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Further evidence for favorable cost-effectiveness of elderly influenza vaccinationMaarten J Postma, Rob Pm Baltussen, Abraham M Palache, et al.
International Journal of Environmental Research and Public Health|April 17, 2020
Inequalities in Rotavirus Vaccine Uptake in Ethiopia: A Decomposition AnalysisAbrham Wondimu, Jurjen van der Schans, Marinus van Hulst, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|July 16, 2016
A comparison of average wages with age-specific wages for assessing indirect productivity losses: analytic simplicity versus analytic precisionMark P Connolly, Cole Tashjian, Nikolaos Kotsopoulos, et al.
Expert Review of Vaccines|June 26, 2024
Economic evaluation of second measles containing vaccine (MCV) dose: a systematic review of available evidenceSamuel Bawa, Abrham Wondimu, Maarten J Postma, et al.
Vaccine|January 21, 2010
Huge impact of assumptions on indirect effects on the cost-effectiveness of routine infant vaccination with 7-valent conjugate vaccine (Prevnar)Mark H Rozenbaum, Albert Jan van Hoek, Eelko Hak, et al.
Expert Review of Vaccines|July 22, 2017
The health-economic studies of HPV vaccination in Southeast Asian countries: a systematic reviewDidik Setiawan, Monika Puri Oktora, Raymond Hutubessy, et al.
Vaccine|May 27, 2020
Cost-effectiveness analysis of a gender-neutral human papillomavirus vaccination program in the NetherlandsJoost J M Simons, Nora Vida, Tjalke A Westra, et al.
Expert Review of Vaccines|January 9, 2004
Pharmacoeconomics of elderly vaccination against invasive pneumococcal infections: cost-effectiveness analyses and implications for The NetherlandsMaarten J Postma, Marie-Louise A Heijnen, Philippe Beutels, et al.
Pageof 49

Showing results (91-100 of 485) with videos related to

Sort By:
Pageof 49
Pharmacoeconomics - Open|March 2, 2026
Cost Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in Older Adults in PortugalEleftherios Zarkadoulas, Fábio Silva, Joana Alves, et al.
Expert Review of Vaccines|July 31, 2008
Cost-effectiveness of varicella vaccination programs: an update of the literatureMark H Rozenbaum, Albert Jan van Hoek, Stefan Vegter, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Further evidence for favorable cost-effectiveness of elderly influenza vaccinationMaarten J Postma, Rob Pm Baltussen, Abraham M Palache, et al.
International Journal of Environmental Research and Public Health|April 17, 2020
Inequalities in Rotavirus Vaccine Uptake in Ethiopia: A Decomposition AnalysisAbrham Wondimu, Jurjen van der Schans, Marinus van Hulst, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|July 16, 2016
A comparison of average wages with age-specific wages for assessing indirect productivity losses: analytic simplicity versus analytic precisionMark P Connolly, Cole Tashjian, Nikolaos Kotsopoulos, et al.
Expert Review of Vaccines|June 26, 2024
Economic evaluation of second measles containing vaccine (MCV) dose: a systematic review of available evidenceSamuel Bawa, Abrham Wondimu, Maarten J Postma, et al.
Vaccine|January 21, 2010
Huge impact of assumptions on indirect effects on the cost-effectiveness of routine infant vaccination with 7-valent conjugate vaccine (Prevnar)Mark H Rozenbaum, Albert Jan van Hoek, Eelko Hak, et al.
Expert Review of Vaccines|July 22, 2017
The health-economic studies of HPV vaccination in Southeast Asian countries: a systematic reviewDidik Setiawan, Monika Puri Oktora, Raymond Hutubessy, et al.
Vaccine|May 27, 2020
Cost-effectiveness analysis of a gender-neutral human papillomavirus vaccination program in the NetherlandsJoost J M Simons, Nora Vida, Tjalke A Westra, et al.
Expert Review of Vaccines|January 9, 2004
Pharmacoeconomics of elderly vaccination against invasive pneumococcal infections: cost-effectiveness analyses and implications for The NetherlandsMaarten J Postma, Marie-Louise A Heijnen, Philippe Beutels, et al.
Pageof 49